Literature DB >> 21766183

Hepatic proliferation after partial liver irradiation in Sprague-Dawley rats.

Zhi-Gang Ren1, Jian-Dong Zhao, Ke Gu, Jian Wang, Guo-Liang Jiang.   

Abstract

The liver has powerful capability to proliferate in response to various injuries, but little is known as to liver proliferation after irradiation (IR) injury. This study investigated whether liver proliferation could be stimulated in low-dose irradiated liver by partial liver IR injury with high dose radiation. Sprague-Dawley rats were irradiated by 6-MV X-ray with single dose of 25 Gy to the right-half liver, while the left-half liver was shielded (0.7 Gy) or irradiated with single doses of 3.2, 5.6, and 8.0 Gy, respectively. Hepatic proliferation in the shielded and low-dose irradiated left-half liver was evaluated by serum hepatic growth factor (HGF), proliferating cell nuclei antigen (PCNA), liver proliferation index (PI), hepatocyte mitosis index (MI). The observation time was 0 day (before IR), 30, 60, 90, and 120 days after IR. Our results showed that serum HGF and hepatocyte HGF mRNA increased after IR with HGF mRNA peak on day 30 in the shielded and low-dose irradiated left-half livers, and their values increased as the dose increased to the left-half liver. Liver PI and PCNA mRNA peaked on day 60 with stronger expressions in higher doses-irradiated livers. MI increased after IR, with the peak noted on day 60 in the shielded and on day 90 in the low-dose irradiated left-half livers. There was a 30 day delay between MI peaks in the shielded and low-dose irradiated livers. In conclusion, 25 Gy partial liver IR injury could stimulate the shielded liver and low-dose irradiated liver to proliferate. In the livers receiving a dose range of 3.2-8.0 Gy, the proliferation was stronger in higher doses-irradiated liver than the low-dose irradiated. However, IR delayed hepatocyte mitosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21766183     DOI: 10.1007/s11033-011-1161-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.

Authors:  Phillip J Taddei; Rebecca M Howell; Sunil Krishnan; Sarah B Scarboro; Dragan Mirkovic; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.

Authors:  L A Dawson; C J McGinn; D Normolle; R K Ten Haken; S Walker; W Ensminger; T S Lawrence
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

Review 3.  DNA damage and cell cycle checkpoints.

Authors:  W K Kaufmann; R S Paules
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

4.  Radiotherapy for hepatocellular carcinoma.

Authors:  K Tokuuye; M Sumi; Y Kagami; S Murayama; M Kawashima; H Ikeda; H Ueno; T Okusaka; S Okada
Journal:  Strahlenther Onkol       Date:  2000-09       Impact factor: 3.621

5.  Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study.

Authors:  Zhi-Gang Ren; Jian-Dong Zhao; Ke Gu; Zhen Chen; Jun-Hua Lin; Zhi-Yong Xu; Wei-Gang Hu; Zhen-Hua Zhou; Lu-Ming Liu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

6.  Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.

Authors:  Z-H Zhou; L-M Liu; W-W Chen; Z-Q Men; J-H Lin; Z Chen; X-J Zhang; G-L Jiang
Journal:  Br J Radiol       Date:  2006-10-12       Impact factor: 3.039

7.  Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.

Authors:  J M Lemire; N Shiojiri; N Fausto
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

8.  Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients.

Authors:  Toshiya Chiba; Koichi Tokuuye; Yasushi Matsuzaki; Shinji Sugahara; Yoshimichi Chuganji; Kenji Kagei; Junichi Shoda; Masaharu Hata; Masato Abei; Hiroshi Igaki; Naomi Tanaka; Yasuyuki Akine
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

9.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury.

Authors:  J P Geraci; M S Mariano
Journal:  Radiat Res       Date:  1993-11       Impact factor: 2.841

View more
  3 in total

1.  Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility.

Authors:  Jiayao Sun; Zheng Wang; Yinxiangzi Sheng; Xue Ming; Guo-Liang Jiang; Weiwei Wang
Journal:  Strahlenther Onkol       Date:  2021-10-07       Impact factor: 3.621

2.  Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.

Authors:  Masumi Imaeda; Hitoshi Ishikawa; Yukari Yoshida; Takeo Takahashi; Yu Ohkubo; Atsushi Musha; Mayumi Komachi; Yoichi Nakazato; Takashi Nakano
Journal:  J Radiat Res       Date:  2014-02-23       Impact factor: 2.724

3.  Protective effect of hydroferrate fluid, MRN-100, against lethality and hematopoietic tissue damage in γ-radiated Nile tilapia, Oreochromis niloticus.

Authors:  Mamdooh Ghoneum; Heba Allah M Elbaghdady; Abdallah A El-Shebly; Deyu Pan; Edward Assanah; Greg Lawson
Journal:  J Radiat Res       Date:  2013-04-14       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.